Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Clinical trials have shown that patients may lose approximately 5% of their initial body weight in the first month of treatment
PlexusDx delivers compounded semaglutide injections tailored to individual needs, at $189/mo month-to-month, or from $149/mo on the 6-month plan with no hidden dose-based charges
Detoxification: Assists in detoxifying the liver and removing harmful substances from the body
It is thought that BPC-157 functions to improve post-surgical recovery by promoting angiogenesis, or new blood vessel development
Ideal candidates are adults struggling with obesity, poor metabolic health, or Type 2 diabetes
About ACHIEVE-1 and ACHIEVE clinical trial program ACHIEVE-1 (NCT05971940) is a Phase 3, 40-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron 3 mg, 12 mg and 36 mg as monotherapy to placebo in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone
US$ 19.99
US$ 26.17
US$ 22.48
US$ 27.88
US$ 28.06
US$ 23.07
US$ 25.84
